← FDA Drug Approvals (Drugs@FDA)
TIGECYCLINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2018-12-21
Drug application
- FDA Application #
ANDA204439- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TIGECYCLINE
- Generic name
- TIGECYCLINE
- Active ingredients
- TIGECYCLINE
- Dosage form
- POWDER
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- APOTEX
- Manufacturer
- Apotex Corp
- First approval
- 2018-12-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown